दवाओं की अंतःक्रिया
Nirsevimab + Palivizumab
गंभीरता: मध्यम
Nirsevimab and Palivizumab: moderate interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Both are monoclonal antibodies that provide passive RSV protection and are used for the same indication. Giving both offers no added benefit and exposes the infant to unnecessary dosing.
इस इंटरैक्शन का सरल भाषा में अर्थ
Nirsevimab and Palivizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nirsevimab belongs to Miscellaneous; Palivizumab belongs to Miscellaneous.
ऐसा क्यों होता है
Therapeutic duplication of RSV F-protein-targeting antibodies; no pharmacokinetic interaction is established.
क्या करें
Do not give palivizumab to infants who have already received nirsevimab in the same RSV season. For infants who had palivizumab first, follow the labeled guidance on switching.
फार्मासिस्ट से क्या पूछें
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Nirsevimab और Palivizumab की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
अक्सर पूछे जाने वाले प्रश्न
Can I take Nirsevimab with Palivizumab?
MediHelp rates the interaction as moderate. Nirsevimab and Palivizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both are monoclonal antibodies that provide passive RSV protection and are used for the same indication. Giving both offers no added benefit and exposes the infant to unnecessary dosing.
How serious is the interaction between Nirsevimab and Palivizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not give palivizumab to infants who have already received nirsevimab in the same RSV season. For infants who had palivizumab first, follow the labeled guidance on switching.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
